Business Trends– category –
-
CUREator+ Funds Six Australian Healthtech Startups with $13.5 Million to Accelerate AI Diagnostics and Digital Health Tool Development
Biotech Dispatch Australia Overview CUREator+ has provided a total of $13.5 million in funding to six Australian healthtech startups through its second funding round. This capital aims to accelerate the development and commercialization ... -
Abbott and Google Health Announce Multi-Year Partnership to Revolutionize Personal Metabolic Health Management with AI-Powered Glucose Insights
PR Newswire USA Overview Abbott and Google Health have announced a multi-year partnership to integrate glucose insights from Abbott's Lingo biowearables with Google's AI and consumer technology, aiming to make personalized metabolic heal... -
Abbott and Medtronic Announce Global Partnership to Integrate FreeStyle Libre CGM Technology into Medtronic Insulin Delivery Systems
Abbott (via Facebook press release), Medtronic USA Overview Medtronic and Abbott have announced a global partnership to integrate Abbott's FreeStyle Libre sensing technology into Medtronic's insulin delivery systems. Under this agreement... -
AI and CDMO Synergy Accelerates End-to-End mRNA Therapeutic Development
SyVento BioTech Poland Overview SyVento BioTech and nCode have forged a strategic partnership to revolutionize mRNA therapeutic development. This collaboration seamlessly integrates nCode's AI-powered mRNA sequence optimization with SyVe... -
SyVento Biotech and Biotechna Forge Alliance to Advance siRNA/LNP Cancer Therapeutics into Clinical Trials
SyVento Biotech Poland Overview SyVento Biotech and Biotechna have announced a strategic partnership to co-develop siRNA/LNP-based anti-cancer therapeutics, targeting solid tumors like lung and breast cancer through precise nucleic acid ... -
EU Updates REACH Restrictions Roadmap 2026, Signals Stronger Commitment to Chemical Safety and Consistent Nanomaterial Regulation
Maven Research EU Overview The European Commission has published an updated REACH Restrictions Roadmap, enhancing transparency on upcoming restrictions and regulatory priorities, including for PFAS. Although no new nanomaterial-specific ... -
AGC Biologics Secures Multi-Million Dollar Manufacturing Deal for Yokohama Facility, Boosting LNP Production Capacity
히트뉴스 Japan Overview AGC Biologics, a global CDMO, has secured a multi-year commercial manufacturing contract, valued at hundreds of millions of dollars, for its new Yokohama facility in Japan, slated to open in 2027. An undisclosed b... -
Curapath Accelerates Advanced Therapeutics Development with GMP Manufacturing Services for Polymer & Lipid Nanoparticles for Nucleic Acid Delivery
Curapath | CPHI Online Global Overview Curapath is offering comprehensive CDMO services specializing in the formulation and scale-up of polymer and lipid nanoparticles for targeted nucleic acid delivery. The company provides GMP manufact... -
Roivant Sciences Receives $771.6 Million Settlement from Moderna Lawsuit, Enters Cross-Licensing Agreement for LNP and GalNAc Technologies
Stock Titan USA Overview Roivant Sciences announced it received a $771.6 million settlement from a lawsuit with Moderna. The settlement includes a comprehensive cross-licensing agreement where Moderna grants Genevant/Arbutus non-exclusiv... -
Precision Delivery: How Biological Barriers and Disease Remodeling Redefine Organ-Targeting Nanomedicine Success
Dove Medical Press New Zealand Overview Organ-targeting nanomedicine efficacy is intricately shaped by biological barriers, disease remodeling, and nanobio interactions, not just anatomical delivery. This review argues for a more rigorou...
